Does GILTERITINIB Cause Pancytopenia? 108 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Pancytopenia have been filed in association with GILTERITINIB (Xospata). This represents 2.9% of all adverse event reports for GILTERITINIB.
108
Reports of Pancytopenia with GILTERITINIB
2.9%
of all GILTERITINIB reports
26
Deaths
41
Hospitalizations
How Dangerous Is Pancytopenia From GILTERITINIB?
Of the 108 reports, 26 (24.1%) resulted in death, 41 (38.0%) required hospitalization, and 5 (4.6%) were considered life-threatening.
Is Pancytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GILTERITINIB. However, 108 reports have been filed with the FAERS database.
What Other Side Effects Does GILTERITINIB Cause?
Acute myeloid leukaemia (366)
Febrile neutropenia (346)
Off label use (334)
Platelet count decreased (327)
Pneumonia (302)
Myelosuppression (300)
Pyrexia (281)
Death (206)
Product use issue (189)
Hepatic function abnormal (181)
What Other Drugs Cause Pancytopenia?
METHOTREXATE (5,377)
CYCLOPHOSPHAMIDE (3,351)
CARBOPLATIN (2,910)
RITUXIMAB (2,400)
LENALIDOMIDE (2,259)
DOXORUBICIN (2,212)
VINCRISTINE (2,180)
ETOPOSIDE (2,129)
DEXAMETHASONE (2,053)
PREDNISONE (1,743)
Which GILTERITINIB Alternatives Have Lower Pancytopenia Risk?
GILTERITINIB vs GIMERACIL\OTERACIL\TEGAFUR
GILTERITINIB vs GINKGO
GILTERITINIB vs GIVINOSTAT
GILTERITINIB vs GIVOSIRAN
GILTERITINIB vs GLASDEGIB